1-3 of 3
Christoph Gasteyger, MD
Close
Sort by
Journal Articles

Economic Benefit of Early Inhospital Diagnosis and Treatment Initiation of Eculizumab in aHUS

Bonnie M.K. Donato, PhD, Michael Ryan, MS, William Irish, PhD, Christoph Gasteyger, MD, Gilbert L'Italien, PhD, Jeffrey Laurence, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3565.
https://doi.org/10.1182/blood-2018-99-112893
Published: 2018
Journal Articles

The Global aHUS Registry: Characteristics of 826 Patients with Atypical Hemolytic Uremic Syndrome

Christoph Licht, MD FRCP(C), FASN, Gianluigi Ardissino, MD PhD, Gema Ariceta, MD PhD, David J. Cohen, MD, Christoph Gasteyger, MD, Laurence A. Greenbaum, MDPhD, Masayo Ogawa, MD FAAP, Varant Kupelian, PhD, Franz Schaefer, MD, Johan Vande Walle, MD PhD, Véronique Frémeaux-Bacchi, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4640.
https://doi.org/10.1182/blood.V126.23.4640.4640
Published: 2015
Journal Articles

Baseline Demographics and Characteristics of 466 Patients with Atypical Hemolytic Uremic Syndrome in the Global aHUS Registry

Christoph Licht, MD FRCP(C), FASN, Gianluigi Ardissino, MD PhD, Gema Ariceta, MD PhD, David Cohen, MD, Christoph Gasteyger, MD, Laurence A. Greenbaum, MDPhD, Masayo Ogawa, MD FAAP, Franz Schaefer, MD, Johan Vande Walle, MD PhD, Veronique Fremeaux-Bacchi, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4204.
https://doi.org/10.1182/blood.V124.21.4204.4204
Published: 2014